FLOTE SMART Gum launches November 2026

Join the waitlist for early access

Every dose disclosed · no proprietary blends

FLOTE SMART Gum launches November 2026

Join the waitlist for early access

Every dose disclosed · no proprietary blends

FLOTE SMART Gum launches November 2026

Join the waitlist for early access

Every dose disclosed · no proprietary blends

What we will and won't say.

Nootropics is a category with a credibility problem, most of it self-inflicted. Blends with impressive totals and unknowable amounts. Percentages from surveys of a few hundred customers, printed as though they were trials. Here is the standard we are holding ourselves to instead.

Named actives, published doses

Every ingredient appears on the label with its own amount. A "proprietary blend" is a way of telling you the total while hiding the split, and the split is the only part that determines whether a dose matches the literature. Where an active has a clinically studied source, we name that source — Ashwagandha KSM-66® in the ready-to-mix line, for instance — rather than listing the genus and hoping you assume the good version.

Mechanism, not promises

We describe what an ingredient is studied for. We do not tell you what it will do to you. Those are different sentences, and the gap between them is where most of this industry's marketing lives. FLOTE SMART is a supplement line — it is not intended to diagnose, treat, cure or prevent anything, and any copy on this site that reads otherwise is a mistake we want reported to support@flotelabs.com.

What each pillar rests on

Focus & clarity

The actives most studied for attention and working memory, in formats you can actually take mid-day.

Studied actives: L-Theanine, Alpha-GPC, Lion's Mane, Bacopa Monnieri

Sustained energy

Energy that comes from metabolism and adaptogens as much as from stimulants — the aim is the absence of a crash, not a bigger peak.

Studied actives: Cordyceps, Rhodiola Rosea, B-vitamin complex, MCT oil

Stress resilience

Adaptogens with a long research history, for the days that ask more of you than usual.

Studied actives: Ashwagandha KSM-66®, Reishi, Chaga, L-Theanine

Evidence, tiered.

Four actives across the line carry the strongest human research in the category. What each is studied for, the protocol that evidence comes from, and — because they are not equal — how the four compare. Doses and durations are the literature's, not a label's.

ActiveStudied forProtocolEvidence base

Calmer, more sustained attention than caffeine alone

Studied as a standard combination dose, not caffeine alone

The most-replicated pairing in nootropic research

Memory consolidation

300–450 mg/day over 12 weeks of consistent use

Strongest evidence base among natural botanicals for memory

Reduced mental fatigue, sustained attention under demanding tasks

Human trials at adaptogen-typical doses

Established adaptogen research base

Lion's Mane

Gum & Mints · Coffee

Nerve growth factor activity; cognition over sustained use

Emerging human research, sustained-use protocols

Promising, but earlier-stage than Bacopa or L-Theanine + caffeine

What evidence does not look like

  • Proprietary "brain blends" that hide individual ingredient doses — you can't verify the dose matches the studied dose.
  • Single-serving claims of dramatic, immediate cognitive gains — most evidence-backed botanicals need weeks of consistent use.
  • Ingredients supported only by animal studies or traditional-use claims, with no human trials at the dose used.
  • Marketing that blurs "focus" and "memory" into one effect — they're different cognitive functions with different evidence behind each.

Numbers we don't have yet

We have not run a consumer study, so there is no "82% felt sharper" on this site. We have no celebrity endorsements, so there are no headshots. When we have either, it will arrive with the methodology attached and a disclosure of the relationship. Until then the absence is the honest answer.

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

Formulations publish at launch.

Be on the list when they do.